Johnson & Johnson's Income Falls 23%


Health care giant Johnson & Johnson says sales rebounded but its profit dropped 23 percent in the first quarter, due to higher expenses, costs of recalls and litigation and a tax gain that boosted results a year ago.

Adjusted earnings topped expectations. J&J also raised its full-year earnings outlook.

The maker of Band-Aids, baby shampoo and birth control pills posted net income of $3.48 billion, or $1.25 per share, down from $4.53 billion, or $1.62 per share, in 2010's first quarter.

But after two years of declines, revenue rose by 3.5 percent to $16.17 billion.

Adjusted income was $4.86 billion, or $1.35 per share. Analysts expected earnings of $1.03 per share and revenue of $15.6 billion.

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA+138.3815,318.23
NASDAQ+30.053,482.18
S&P 500+12.771,651.81

Last updated: June 19, 2013: 12:06 AM

Hot Stocks

General Electric

24.33+0.56(+2.36)

Alcoa

8.21+0.10(+1.23)

Apple Inc

431.77-0.23(-0.05)

Google Inc 'A'

900.62+14.37(+1.62)

Bank of America

13.27+0.06(+0.45)

Wal-Mart Stores

75.73+0.78(+1.04)

Exxon Mobil Corp

91.93+0.42(+0.46)

Ford

15.65+0.10(+0.64)

Citigroup

50.01+0.65(+1.32)

IBM

204.87+1.83(+0.90)

Yahoo

26.66+0.12(+0.45)

Starbucks

67.095+1.065(+1.61)

Microsoft

34.98-0.02(-0.06)

Home Depot

77.19+1.05(+1.38)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1371614814699 ms.